Trials / Conditions / Hypereosinophilia
Hypereosinophilia
3 registered clinical trials studyying Hypereosinophilia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French Guiana NCT03378882 | University Hospital Center of Martinique | — |
| Unknown | Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome NCT02130882 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) NCT00086658 | GlaxoSmithKline | Phase 3 |